HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 181 filers reported holding HAEMONETICS CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,957,144 | -68.4% | 21,848 | -70.0% | 0.00% | -66.7% |
| Q2 2023 | $6,194,190 | +12.7% | 72,753 | -29.8% | 0.01% | +20.0% |
| Q4 2021 | $5,494,000 | +342.4% | 103,583 | +890.4% | 0.01% | +42.9% |
| Q4 2020 | $1,242,000 | -83.6% | 10,459 | -88.0% | 0.01% | -85.7% |
| Q3 2020 | $7,583,000 | +122.0% | 86,911 | +127.9% | 0.05% | +104.2% |
| Q2 2020 | $3,415,000 | +728.9% | 38,132 | +964.2% | 0.02% | +700.0% |
| Q4 2019 | $412,000 | -97.8% | 3,583 | -97.6% | 0.00% | -98.0% |
| Q2 2019 | $18,335,000 | +109.7% | 152,363 | +52.4% | 0.15% | +268.3% |
| Q1 2019 | $8,744,000 | +4207.4% | 99,958 | +4324.9% | 0.04% | +1266.7% |
| Q2 2018 | $203,000 | -7.7% | 2,259 | -25.0% | 0.00% | -66.7% |
| Q1 2018 | $220,000 | -70.7% | 3,013 | -88.4% | 0.01% | +50.0% |
| Q2 2016 | $752,000 | -70.5% | 25,949 | -64.3% | 0.01% | -76.0% |
| Q1 2016 | $2,546,000 | – | 72,771 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |